The FDA has approved Awiqli, the first once‑weekly long‑acting basal insulin, for adults with type 2 diabetes, which offers ...
Researchers have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with Type 2 Diabetes, ...
Age-related muscle loss is an often unaddressed problem whose impact goes beyond strength and mobility. Dr Sood shares other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results